Most Recent
Court may scrap expanded class definition in Ethicon pelvic mesh case as judgment looms
Andrew Naylor 2019-10-30 10:52 pm By Miklos Bolza Sydney

An impending judgment in the long-running class action against Johnson & Johnson unit Ethicon over allegedly defective pelvic mesh implants has sent the parties scrambling about opt out notices and the Federal Court considering reversing prior orders that expanded the group definition.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Insurers may get dragged into class action over ‘botched’ breast implants
Class Actions 2019-10-25 9:03 pm By Miklos Bolza Sydney

Cosmetic Institute director Dr Eddy Dona has flagged that he may drag insurers of his now collapsed medical chain into a class action brought against him and the company over allegedly botched breast implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Kymab to attack Regeneron’s mice experiments in human rat patent case
Ben Mee 2019-10-24 7:39 pm By Miklos Bolza Sydney

UK biopharmaceutical company Kymab may attack experiments done by US biotechnology giant Regeneron creating genetically modified mice with splices of human genomes, as it defends its proposed patent for a human rat.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ex-Prime Trust director Wooldridge seeks court approval to manage companies despite recent ban
Corporate 2019-10-24 6:58 pm By Cat Fredenburgh Melbourne

Former health minister and Prime Trust director Michael Wooldridge wants court approval to manage four corporations, despite a recent ruling from the Full Federal Court that reimposed a ban on him and three other former directors of the collapsed retirement village for violations of the Corporations Act.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Monsanto faces class action in Australia over Roundup weedkiller
Class Actions 2019-10-21 10:25 am By Cat Fredenburgh

Agricultural giant Monsanto is facing a class action in Australia over the marketing of its Roundup weedkiller, after being hit with a landmark US$ 2 billion verdict in the United States.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Medibank admits to violating consumer law with insurance cover fail
Baker McKenzie 2019-10-16 1:11 pm By Cat Fredenburgh Melbourne

Health insurer Medibank has admitted to engaging in misleading and deceptive conduct when it falsely told consumers they were not eligible for certain coverage under their insurance policies in what it called an “internal process failure”, but denies the ACCC’s claim that consumers were denied the benefits they paid for.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Full Federal Court reimposes ban on Prime Trust directors
Appeals 2019-10-15 12:43 am By Cat Fredenburgh Melbourne

The Full Federal Court has reimposed bans against four former directors of collapsed retirement village owner Prime Trust, including former federal health minister Michael Wooldridge, following a successful High Court challenge by the Australian Securities and Investments Commission.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Smiles Inclusive may face investor class action over IPO
Class Actions 2019-10-09 6:37 pm By Amelia Birnie Sydney

National law firm Holding Redlich is investigating a shareholder class action against Smiles Inclusive, just one week after the embattled Gold Coast dental company reported a $31 million statutory loss.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Interpharma won’t challenge Precedex patent validity ruling
Healthcare 2019-10-03 8:54 pm By Cat Fredenburgh Melbourne

Australian drug maker InterPharma will not appeal a ruling that dismissed its challenge to the validity of global pharmaceutical giant Pfizer’s patent for sedative drug Precedex.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

University of Sydney wins IP rights case against ObjectiVision
Allens 2019-10-02 3:34 pm By Miklos Bolza Sydney

The University of Sydney has emerged triumphant in its long running battle over the intellectual property rights of a glaucoma testing device, with the Federal Court ruling against opthalmic diagnostic tool manufacturer ObjectiVision.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?